SciELO - Scientific Electronic Library Online

 
vol.130 número8Anticuerpos a proteínas recombinantes Ro60 Kd, Ro52 Kd y La48 Kd, en el síndrome de Sjögren primario: Utilidad de la combinación de métodos analíticos para detectar anticuerpos anti Ro y anti LaPortación de Staphylococcus aureus enterotoxigénicos en manipuladores de alimentos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

MOLINA F, Graciela et al. Clinical and molecular genetic study of cystic fibrosis in the 5th Region of Chile. Rev. méd. Chile [online]. 2002, vol.130, n.8, pp.850-858. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872002000800002.

Background: Cystic fibrosis (CF) is the most common autosomal recessive disease in Caucasian population. More than 900 mutations have been detected in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene. The most common worldwide, is a deletion of phenylalanine 508 (DF508). Aim: To analyze the presence of mutations ∆F508, G542X, N1303K, G551D, R553X and S549N in patients from the 5th Region of Chile, with a clinical diagnosis of CF. Patients and methods: We studied 17 non-related patients, presenting frequent respiratory tract infections, malabsorption and positive sweat tests, or meconial ileum. Serum immunoglobulins (IgG, IgA, IgM), and total, CD3+ and B-lymphocytes, were determined to discard the presence of an immune deficiency. The molecular study of the gene was performed by Polymerase Chain Reaction amplification and restriction analysis. Results: Immunological parameters were normal in all patients. The DF508 mutation was detected in 11 chromosomes and the mutation G542X in 3 chromosomes. Conclusions: The mutation G542X was the second most frequent mutation found in this sample of Chilean CF patients. Since this mutation has a high frequency in Spanish CF patients, we suggest that this mutation might have had its origin in Spain (Rev Méd Chile 2002; 130: 850-8)

Palabras clave : Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Mutation; Suppression, genetic.

        · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons